Unlocking the Adherence Puzzle in Acne Management Have you read this latest insightful review from the Journal of Drugs in Dermatology (JDD)? Acne vulgaris remains one of the most frequent...
Targeting Fibroproliferative Disorders: Could JAK Inhibitors Lower Keloid and Hypertrophic Scar Risk? Here is an essential new report from the JDD that could shift how we think about scar prevention....
Check Out JDD’s Latest Author Spotlight Our current Author Spotlight features Jessica L. Feig MD PhD, one of the co-authors of JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic...
JDD Multimedia Love33 Prescription-Strength Acne Science, Now OTC: The Clinical Confidence Behind Differin® Epiduo® Join us for a webinar on the launch of Differin® Epiduo®, the first dual-active acne treatment...
Unlocking the Adherence Puzzle in Acne Management Have you read this latest insightful review from the Journal of Drugs in Dermatology (JDD)? Acne vulgaris remains one of the most frequent...
Targeting Fibroproliferative Disorders: Could JAK Inhibitors Lower Keloid and Hypertrophic Scar Risk? Here is an essential new report from the JDD that could shift how we think about scar prevention....
Check Out JDD’s Latest Author Spotlight Our current Author Spotlight features Jessica L. Feig MD PhD, one of the co-authors of JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic...
JDD Multimedia Love33 Prescription-Strength Acne Science, Now OTC: The Clinical Confidence Behind Differin® Epiduo® Join us for a webinar on the launch of Differin® Epiduo®, the first dual-active acne treatment...
